Published 2 hours ago • loading... • Updated 34 minutes ago
Psyence BioMed Announces Strategic Ibogaine Investment
Summary by Financial Post
7 Articles
7 Articles
+6 Reposted by 6 other sources
Psyence BioMed Announces Strategic Ibogaine Investment
Transactions include an investment of up to US$5 million in PsyLabs and an approximately US$9 million value-matched share exchange
Coverage Details
Total News Sources7
Leaning Left4Leaning Right2Center1Last Updated57% Left
Bias Distribution
- 57% of the sources lean Left
57% Left
L 57%
14%
R 29%
Factuality
To view factuality data please Upgrade to Premium












